The team used two-photon microscopy to track living mouse brains over several weeks, combined with spatiotemporal gene expression mapping . They found that these perilesional astrocytes undergo pronounced structural remodeling during lesion repopulation, characterized by cell proliferation, prolonged multinucleated states, and the eventual migration of daughter cell nuclei into unoccupied astrocyte territories .
The research identified numerous genes and signaling pathways that are temporarily activated during this repair process . These pathways could serve as drug targets for stimulating regeneration in human patients. The repair process transforms a subset of mature astrocytes into reactive progenitor-like (REPL) astrocytes that undergo multiple asymmetric divisions and remain in a multinucleated interstage, facilitating efficient migration of nuclei .
The discovery directly addresses conditions where astrocytes are destroyed, such as:
If the nuclear translocation mechanism can be pharmacologically activated or enhanced, it could improve recovery by restoring lost astrocyte networks in these patients .
A separate but related 2025/2026 Nature study found that "lesion-remote astrocytes" (LRAs) far from the injury site secrete the protein CCN1, which reprograms microglia to clear myelin debris and support neurological recovery after spinal cord injury . This complementary mechanism shows that astrocytes possess multiple, previously unappreciated strategies for CNS repair — both long-distance signaling and local nuclear migration.
Together, these findings represent a major shift in understanding how the brain heals itself. The adult brain evidently possesses far greater self-repair capacity than previously assumed, and identifying the precise molecular levers that control these regenerative programs opens a new frontier for treating a range of neurological conditions.